Teriparatide Price Comparison

View full research →
Osteoporosis at high fracture riskSafety Rating 8/10

Price Comparison

Compare vendors

No vendor pricing available for this peptide yet.

Research details

Teriparatide — research data

Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.

Research dose range20 mcg once daily SC
AdministrationSubcutaneous injection
Safety8/10 · FDA-approved (Forteo)
NCAA D1Not listed

Overview

About Teriparatide

Mechanism of action

Recombinant PTH 1-34; anabolic bone building through osteoblast stimulation and activation

Safety profile

Orthostatic hypotension, leg cramps, osteosarcoma risk (black box warning) · Approved for osteoporosis; 2-year limit (animal osteosarcoma); well-characterized in humans

📈

Price tracking starts now.

Set an alert to get notified when this peptide drops.

Related pages

More on Teriparatide

Failed to fetch